Characteristics of glucagon-like peptide-1 receptor agonist (GLP-1 RA)-associated psychiatric disorders: adverse event (AE) reports sourced from the FDA Adverse Event Reporting System (FAERS) database (Q1 2004–Q1 2023). Here, GLP1R is linked to psychiatric disorder.